U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H14N4
Molecular Weight 298.3413
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GW-6604

SMILES

N1C=C(C(=N1)C2=NC=CC=C2)C3=CC(=NC=C3)C4=CC=CC=C4

InChI

InChIKey=BDCBRQYHYNUWAM-UHFFFAOYSA-N
InChI=1S/C19H14N4/c1-2-6-14(7-3-1)18-12-15(9-11-21-18)16-13-22-23-19(16)17-8-4-5-10-20-17/h1-13H,(H,22,23)

HIDE SMILES / InChI

Molecular Formula C19H14N4
Molecular Weight 298.3413
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Inhibition of ALK5 as a new approach to treat liver fibrotic diseases.
2006 Mar
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:52:25 GMT 2023
Edited
by admin
on Sat Dec 16 07:52:25 GMT 2023
Record UNII
273G6SN31H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GW-6604
Common Name English
2-PHENYL-4-(3-(PYRIDIN-2-YL)-1H-PYRAZOL-4-YL)PYRIDINE
Systematic Name English
PYRIDINE, 2-PHENYL-4-(3-(2-PYRIDINYL)-1H-PYRAZOL-4-YL)-
Systematic Name English
Code System Code Type Description
CAS
452342-37-9
Created by admin on Sat Dec 16 07:52:25 GMT 2023 , Edited by admin on Sat Dec 16 07:52:25 GMT 2023
PRIMARY
PUBCHEM
9861063
Created by admin on Sat Dec 16 07:52:25 GMT 2023 , Edited by admin on Sat Dec 16 07:52:25 GMT 2023
PRIMARY
FDA UNII
273G6SN31H
Created by admin on Sat Dec 16 07:52:25 GMT 2023 , Edited by admin on Sat Dec 16 07:52:25 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY